Similar Articles

Browse Main Topics:

Business
Computers & Electronics
Education & Reference
Entertainment & Leisure
Family & Home
Finance & Investment
Health
Internet
Pets & Animals
Science & Technology
Society, Politics & Culture
Sports & Recreation

Similar Articles

The Motley Fool May 5, 2004 Mike Cianciolo	CVS Prescribes Growth The soon-to-be leader of the drugstore market had a spectacular first quarter as a result of improved sales and margins, and CVS doesn't appear to be showing any signs of slowing down either, as the company continues to expand its business in both traditional and creative ways.
The Motley Fool June 10, 2004 Alyce Lomax	Summer Starts at CVS The drugstore company releases same-store sales results on the cusp of its Eckerd acquisition.
The Motley Fool March 5, 2004 Dave Marino-Nachison	Longs Coming Up Short Investors who bid on a Longs buyout haven't been rewarded in recent months.
The Motley Fool March 22, 2004 Alyce Lomax	Walgreen's Green Quarter Investors take an earnings miss to heart. But the future looks good.
The Motley Fool June 2, 2004 Alyce Lomax	Walgreen's Mellow May Will the drugstore chain get a taste of its own medicine?
The Motley Fool November 10, 2004 Dave Marino-Nachison	Investors Adjusting to Larger CVS The drugstore company's chains have done nothing but rise since the Eckerd buy. Investors have pulled the company's shares steadily upward since the merger closed.
The Motley Fool July 5, 2005 Alyce Lomax	Business As Usual at Walgreen Walgreen's same-store sales for June certainly don't disappoint. Investors might question whether the retail pharmacy can keep up the great work.
The Motley Fool July 6, 2004 Alyce Lomax	Not Ready for Rite Aid Can the drugstore chain hold a candle to the competition? Its shares are trading at 22 times forward earnings, making it a seemingly less-than-advantageous time to place a bet on them.
The Motley Fool August 17, 2004 Nathan Slaughter	J.C. Penney on the Rise The retailer hits its stride after shedding Eckerd Drugstores.
The Motley Fool July 6, 2004 Steven Mallas	Walgreen's Sunny Sales The retail pharmacy has a resplendently ruddy June, with comp sales increasing more than 10%.
The Motley Fool March 3, 2004 Dave Marino-Nachison	Pacific Sunwear Catches a Break The apparel retailer's earnings report reveals some impressive numbers.
The Motley Fool February 2, 2005 Alyce Lomax	CVS's Shot in the Arm Buying the Eckerd drugstore chain from J.C. Penney was apparently a good move for CVS. It continues to benefit from the purchase, reporting positive earnings and beating analysts' expectations by a penny.
The Motley Fool April 5, 2004 Dave Marino-Nachison	Finally, Eckerd Sells J.C. Penney's drugstore operation will be split between CVS and Jean Coutu.
The Motley Fool February 5, 2004 Dave Marino-Nachison	Aeropostale Flying High The teen apparel retailer managed a same-store sales gain of nearly 18% in January.
The Motley Fool February 19, 2004 W.D. Crotty	The Wal-Mart Monster Wal-Mart is frighteningly strong and getting stronger by the day.
The Motley Fool January 6, 2004 Dave Marino-Nachison	Tweeter Under Pressure The more the electronics retailer is forced to cut prices, the more trouble it will have competing.
The Motley Fool February 26, 2004 Alyce Lomax	Pinching J.C. Penney Eckerd is still a pain, but will Penney fly when it's on its own? Penney's reported a net loss of $1.07 billion, or $3.42 per share, as compared to earnings of $202 million, or $0.68 per share, in the same quarter last year.
The Motley Fool February 24, 2004 Alyce Lomax	Federated's Fresh Quarter It's been a busy couple of months for the name behind Bloomingdale's and Macy's.
The Motley Fool September 24, 2004 Seth Jayson	Kick This Drug Habit Rite Aid offers slow sales and minuscule shareholder rewards.
The Motley Fool February 11, 2004 Dave Marino-Nachison	Unwrapping Office Depot The office supply giant is counting on a return to health in 2004.
The Motley Fool January 3, 2005 Nathan Slaughter	Walgreen Seeing Green Rivals CVS and Rite Aid have a bitter pill to swallow as Walgreen stays strong. While Walgreen's revenues were in line with forecasts, the stronger-than-expected bottom line has the stock gaining ground.
The Motley Fool August 26, 2004 Dave Marino-Nachison	Getting Into Gottschalks A look at West Coast retailer Gottschalks reveals a market-crushing year-to-date run.
The Motley Fool February 4, 2004 Dave Marino-Nachison	Cache's Catching On It was a good 2003 for the women's clothier, which looks to grow further this year.
The Motley Fool February 27, 2004 Dave Marino-Nachison	Out in the Kohl's The retailer's sales keep booming, but expenses are pressuring profits.
The Motley Fool August 15, 2005 Bobby Shethia	Walgreen's Prescription for Success The drugstore chain's smart and steady growth makes it a good choice for investors.
The Motley Fool April 9, 2007 Mike Cianciolo	CVS: Continued Vigorous Sales The drugstore chain grows sales and itself in March. Investors, take note.
The Motley Fool May 18, 2004 Seth Jayson	Perky Days for J.C. Penney This cornerstone of the American mall is outrunning its rivals.
The Motley Fool March 26, 2007 Ryan Fuhrmann	A Healthy Shade of Walgreen: Fool by Numbers The drugstore chain released second-quarter 2007 results: Income Statement Highlights... Margin Checkup... Balance Sheet Highlights... Cash Flow Highlights...
The Motley Fool February 22, 2007 Ryan Fuhrmann	Fashionable Results From J.C. Penney: Fool by Numbers The department store retailer released fourth-quarter and year-end 2006 results: Income Statement Highlights... Margin Checkup... Balance Sheet Highlights... Cash Flow Highlights...
The Motley Fool May 9, 2005 Timothy M. Otte	Flu Means All's Well for CVS Strong comp sales and benefits from the Eckerd acquisition drive CVS to a solid first quarter. Investors, take note.
The Motley Fool March 17, 2004 Dave Marino-Nachison	S&K's Holidays Fray The men's apparel discounter's holidays held back promising full-year results.
The Motley Fool August 4, 2004 Phil Wohl	CVS's Prescription for Competition The national drugstore chain is looking to take advantage of increased size.
The Motley Fool December 23, 2003 Dave Marino-Nachison	Duane Reade's NY Story The well-known New York drugstore chain is going private after just under six years.
The Motley Fool August 3, 2004 Rich Duprey	Penney Kicks Drugstore Habit The retailer has completed its sale of Eckerd Drugs to focus on selling clothes. While investors can and should enjoy Penney's current clear-eyed plans, they ought to keep a watchful eye out for any relapse.
The Motley Fool June 25, 2004 Steven Mallas	Rite Aid in the Shadows The first quarter for Rite Aid, the pharmaceutical retailer, shows a profit, but is it time to add this stock to your portfolio?
The Motley Fool January 13, 2004 Alyce Lomax	CVS Fever Drug stores benefit from the flu bug, but for how much longer?
The Motley Fool February 19, 2004 Dave Marino-Nachison	Jones Apparel Shops for Profits An improved job market and wider operating margins would help the apparel company.
The Motley Fool January 16, 2004 Dave Marino-Nachison	Blurred Future for Concord Camera Changes in the product mix are undoing recent manufacturing cost improvements.
The Motley Fool February 18, 2004 Dave Marino-Nachison	Zale's Clean-Cut Quarter Decent holiday profit growth and a clean image have helped the jeweler's shares.
The Motley Fool August 11, 2004 Nathan Slaughter	Brinker Takes Bite out of Outlook Chili's parent posts strong fourth-quarter earnings, but lowers guidance.
The Motley Fool August 19, 2004 Nathan Slaughter	Dillard's Dullness The retailer tumbles after missing earnings estimates.
The Motley Fool June 21, 2004 Seth Jayson	Walgreen's Fine Follow-Up It's another solid quarter for America's soon-to-be No. 2 drugstore.
The Motley Fool February 3, 2006 Nathan Parmelee	CVS Looks Healthy The drugstore chain handles acquisitions without faltering -- this stock may be worth considering.
The Motley Fool January 5, 2004 Jeff Hwang	Prescriptions Boost Walgreen Earnings and sales bumped by early flu season and improved non-pharmacy sales.
The Motley Fool February 1, 2007 Ryan Fuhrmann	Busy Aisles at CVS: Fool by Numbers The drugstore retailer released fourth-quarter and 2006 year-end results: Income Statement Highlights... Margin Checkup... Balance Sheet Highlights... Cash Flow Highlights...
The Motley Fool March 6, 2008 Timothy M. Otte	Longs Drugs Has a Nice Niche West Coast regional drugstore chain scores solid fourth quarter.
The Motley Fool March 9, 2004 Alyce Lomax	February Frenzy at CVS, Rite Aid The flu season's early end hasn't stopped drugstore retailers.
The Motley Fool February 26, 2004 W.D. Crotty	Victoria's Not So Secret As expected, fourth-quarter results released this morning were strong. Same-store sales were up a robust 8%, revenue increased 9%, and net income rose 10% over the prior-year period.
The Motley Fool March 26, 2004 Dave Marino-Nachison	Stride Rite Stumbles The shoe company loses its footing, but still expects solid profit growth this year.
The Motley Fool August 8, 2005 Mike Cianciolo	A Cautiously Optimistic CVS The retail pharmacy nudges guidance up after an impressive quarter. All things considered, the outlook seems bright for investors in this company.